BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study

Conditions:   Hurler Syndrome;   Inherited Metabolic Disorder;   Lysosomal Storage Disorder;   Metachromatic Leukodystrophy;   Inborn Errors of Metabolism Interventions:   Biological: rivogenlecleucel;   Drug: rimiducid Sponsor:   Bellicum Pharmaceuticals Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials